The Effect of Prior Nondefinitive Surgery on Perioperative Outcomes and Survival in Mucinous Appendix Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

<b>Introduction:</b> Peritoneal metastases (PM) from mucinous appendix cancer (MAC) are common and often mismanaged. While cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is standard, many patients undergo nondefinitive surgery. We compared outcomes in MAC patients undergoing CRS/HIPEC after limited vs excessive prior surgeries. <b>Methods:</b> We conducted a retrospective analysis of MAC patients (1998-2023) from a single-center prospective database who underwent CRS/HIPEC. Surgical history was evaluated using the prior surgical score (PSS). Perioperative characteristics were compared between PSS-0/1 and PSS-2/3 groups. Logistic regression identified factors associated with extensive prior surgery. Overall survival (OS) was analyzed with Kaplan-Meier and Cox regression. <b>Results:</b> Of 351 eligible cases, 221 (63%) had PSS-0/1 and 130 (37%) had PSS-2/3. Most individuals with PSS-2/3 were women (89.2%, n = 116). Only female sex was significantly associated with the higher likelihood of PSS-2/3 (odds ratio: 9.02, <i>P</i> < .001). PSS-2/3 patients had longer time from diagnosis to CRS/HIPEC (<i>P</i> < .001), longer CRS/HIPEC procedure (<i>P</i> = .007), and greater blood loss (<i>P</i> = .038). Complete cytoreduction (CC) rates were similar (<i>P</i> = .227). Despite comparable major complication rates, PSS-2/3 patients had more transfusions (<i>P</i> = .016), infections (<i>P</i> = .048), and pulmonary complications (<i>P</i> = .028). Five-year OS was 76% and 66% for PSS-0/1 and PSS-2/3 groups, respectively (<i>P</i> = .049). After adjusting for age, tumor burden, CC-score, and histology, PSS-2/3 was not significantly associated with shorter OS (hazard ratio: 1.32; <i>P</i> = .139). <b>Conclusion:</b> Females with MAC are more likely to have extensive surgeries, delaying CRS/HIPEC and compromising safety. This highlights the importance of general surgeons and gynecologists limiting the surgical extent and referring patients to an HIPEC center.

Authors

Institutions

Publication Details

Journal
The American Surgeon
Published
2025-06-30
DOI
https://doi.org/10.1177/00031348251353806
Primary Topic
Intraperitoneal and Appendiceal Malignancies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effect of Prior Nondefinitive Surgery on Perioperative Outcomes and Survival in Mucinous Appendix Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Luis Felipe Falla-Zúñiga, Mary Caitlin King, Vladislav Kovalik, Armando Sardi et al.
2 links
The American Surgeon
Intraperitoneal and Appendiceal Malignancies
article

The Effect of Prior Nondefinitive Surgery on Perioperative Outcomes and Survival in Mucinous Appendix Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Luis Felipe Falla-Zúñiga, Mary Caitlin King, Vladislav Kovalik, Armando Sardi, Vadim Gushchin, Sergei Iugai, Carol Nieroda, Kseniia Uzhegova
article en

Abstract

<b>Introduction:</b> Peritoneal metastases (PM) from mucinous appendix cancer (MAC) are common and often mismanaged. While cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is standard, many patients undergo nondefinitive surgery. We compared outcomes in MAC patients undergoing CRS/HIPEC after limited vs excessive prior surgeries. <b>Methods:</b> We conducted a retrospective analysis of MAC patients (1998-2023) from a single-center prospective database who underwent CRS/HIPEC. Surgical history was evaluated using the prior surgical score (PSS). Perioperative characteristics were compared between PSS-0/1 and PSS-2/3 groups. Logistic regression identified factors associated with extensive prior surgery. Overall survival (OS) was analyzed with Kaplan-Meier and Cox regression. <b>Results:</b> Of 351 eligible cases, 221 (63%) had PSS-0/1 and 130 (37%) had PSS-2/3. Most individuals with PSS-2/3 were women (89.2%, n = 116). Only female sex was significantly associated with the higher likelihood of PSS-2/3 (odds ratio: 9.02, <i>P</i> < .001). PSS-2/3 patients had longer time from diagnosis to CRS/HIPEC (<i>P</i> < .001), longer CRS/HIPEC procedure (<i>P</i> = .007), and greater blood loss (<i>P</i> = .038). Complete cytoreduction (CC) rates were similar (<i>P</i> = .227). Despite comparable major complication rates, PSS-2/3 patients had more transfusions (<i>P</i> = .016), infections (<i>P</i> = .048), and pulmonary complications (<i>P</i> = .028). Five-year OS was 76% and 66% for PSS-0/1 and PSS-2/3 groups, respectively (<i>P</i> = .049). After adjusting for age, tumor burden, CC-score, and histology, PSS-2/3 was not significantly associated with shorter OS (hazard ratio: 1.32; <i>P</i> = .139). <b>Conclusion:</b> Females with MAC are more likely to have extensive surgeries, delaying CRS/HIPEC and compromising safety. This highlights the importance of general surgeons and gynecologists limiting the surgical extent and referring patients to an HIPEC center.

The American Surgeon
Mercy Medical Center (US)
Good health and well-being
Openalex Percentile: Top 74%
Intraperitoneal and Appendiceal Malignancies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.